Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

2

Revenue 2017

Novartis

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Novartis' 2013 sales performance.

Novartis

Novartis and Precision BioSciences announce in vivo gene editing collaboration

Novartis and Precision BioSciences announce in vivo gene editing collaboration

Novartis and Precision BioSciences (Precision) have announced an in vivo gene editing research and development collaboration to develop potentially curative treatments for disorders including sickle cell disease (SCD) and beta thalassaemia.

Pfizer donates $5m in Russian profits to humanitarian causes amid war in Ukraine

Pfizer donates $5m in Russian profits to humanitarian causes amid war in Ukraine Pfizer is joined with more than two dozen pharma companies with European operations who have pledged support for Ukraine, including AbbVie, Amgen, AstraZeneca, GlaxoSmithKline, Eli Lilly, Merck and Novartis.

Novartis endorses Kigali Declaration by investing $250m for tropical diseases

Novartis endorses Kigali Declaration by investing $250m for tropical diseases $100m of the investment will be used to advance research and development of Novartis’ NTD programme, that includes Chagas disease, leishmaniasis, dengue and cryptosporidiosis. ... Novartis will continue progressing our longstanding commitment to

Novartis publishes final positive phase 3 results of Zolgensma in Nature Medicine

Novartis publishes final positive phase 3 results of Zolgensma in Nature Medicine Final results from Novartis’ phase 3 SPR1NT trial assessing Zolgensma (onasemnogene abeparvovec) have been published in Nature Medicine. ... presymptomatic babies with SMA,” said Shephard Mpofu, senior vice president, chief medical officer, Novartis

New virtual health and care report from WHO and Novartis calls for ‘critical action’

New virtual health and care report from WHO and Novartis calls for ‘critical action’ by the World Health Organization (WHO) and the Novartis Foundation (Novartis), details how the past two years have changed access to health and care in 23 countries. ... People who need help to access or navigate virtual health services, for example,

1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
Six Degrees Medical Consulting

For over a decade, our medical communication services have helped pharmaceutical companies optimize their brand, disease and corporate objectives. Building...

Latest intelligence

The Evolving Role of the Sales Rep
The COVID-19 pandemic sparked an evolution in physician engagement. Jill Padgett, EdD, Head of Training, explores what this means for the sales force and shares her advice for succeeding in...
Measure your omnichannel maturity with our new tool
Try our Omnichannel Maturity Tool to gain tangible advice and an instant analysis of your omnichannel readiness....
Report: Omnichannel advice for the life science industry
In the latest issue of Delta magazine, Fishawack Health's Medical, Marketing, and Consulting experts share their practical advice for creating meaningful omnichannel stakeholder experiences and reveal our proprietary tool for...